EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Hidenori Fukuoka(Cedars-Sinai Medical Center), Шломо Мелмед(Cedars-Sinai Medical Center)
Cited by 256
Related Papers
PPAR-γ receptor ligands: novel therapy for pituitary adenomas
|Journal of Clinical Investigation|2003|164
ErbB Receptor-Driven Prolactinomas Respond to Targeted Lapatinib Treatment in Female Transgenic Mice
|Endocrinology|2014|37
Clusterin and FOXL2 Act Concordantly to Regulate Pituitary Gonadotroph Adenoma Growth
|Molecular Endocrinology|2012|30